BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11754202)

  • 1. Quantification of the leukocyte common antigen (CD45) in mature B-cell malignancies.
    Hendrickx A; Bossuyt X
    Cytometry; 2001 Dec; 46(6):336-9. PubMed ID: 11754202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
    Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
    Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
    Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias.
    Lavabre-Bertrand T; Duperray C; Brunet C; Poncelet P; Exbrayat C; Bourquard P; Lavabre-Bertrand C; Brochier J; Navarro M; Janossy G
    Leukemia; 1994 Mar; 8(3):402-8. PubMed ID: 8127145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between CD45 antigen expression and putative stages of differentiation in B-cell malignancies.
    Caldwell CW; Patterson WP
    Am J Hematol; 1991 Feb; 36(2):111-5. PubMed ID: 1849347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
    Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
    Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
    Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
    Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
    Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
    Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of CD5 in B-cell chronic lymphoproliferative diseases by flow cytometry: a strong expression in B-cell chronic lymphocytic leukemia.
    Cavalcanti Júnior GB; Sales VS; Cavalcanti e Silva DG; Lopes MC; Paiva Ade S; da Fonseca HE; do Nascimento Júniors FF; Fernandes MZ
    Acta Cir Bras; 2005; 20 Suppl 1():101-7. PubMed ID: 16186976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hairy cell leukaemia in blood and bone marrow using multidimensional flow cytometry with CD45-PECy5 and SS gating.
    Tytherleigh L; Taparia M; Leahy MF
    Clin Lab Haematol; 2001 Dec; 23(6):385-90. PubMed ID: 11843886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of CD307a expression patterns during normal B-cell maturation and in B-cell malignancies by flow cytometry.
    Auat M; Cardoso CC; Santos-Pirath IM; Rudolf-Oliveira RCM; Matiollo C; Lange BG; da Silva JP; Dametto GC; Pirolli MM; Colombo MDHP; Santos-Silva MC
    Cytometry B Clin Cytom; 2018 Jul; 94(4):588-595. PubMed ID: 29476700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential and tumor-specific expression of CD160 in B-cell malignancies.
    Farren TW; Giustiniani J; Liu FT; Tsitsikas DA; Macey MG; Cavenagh JD; Oakervee HE; Taussig D; Newland AC; Calaminici M; Bensussan A; Jenner M; Gribben JG; Agrawal SG
    Blood; 2011 Aug; 118(8):2174-83. PubMed ID: 21715317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD2 is expressed by a subpopulation of normal B cells and is frequently present in mature B-cell neoplasms.
    Kingma DW; Imus P; Xie XY; Jasper G; Sorbara L; Stewart C; Stetler-Stevenson M
    Cytometry; 2002 Oct; 50(5):243-8. PubMed ID: 12360573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD45 isoforms in chronic B-cell leukaemias.
    Zola H; Siderius N; Flego L; Sparrow R; van der Weyden MB; Nimmo J; Hart DN; Houghton S; Boyd AW
    Leuk Res; 1993 Mar; 17(3):209-16. PubMed ID: 7680734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variables affecting the quantitation of CD22 in neoplastic B cells.
    Jasper GA; Arun I; Venzon D; Kreitman RJ; Wayne AS; Yuan CM; Marti GE; Stetler-Stevenson M
    Cytometry B Clin Cytom; 2011 Mar; 80(2):83-90. PubMed ID: 20872890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-ly-7, a monoclonal antibody reactive with hairy cell leukemia, also defines an activation antigen on normal CD8+ T cells.
    Mulligan SP; Travade P; Matutes E; Dearden C; Visser L; Poppema S; Catovsky D
    Blood; 1990 Sep; 76(5):959-64. PubMed ID: 2118401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory aspects of clonally expanded B-1 (CD5+ B) cells.
    Raveché ES; Phillips J; Mahboudi F; Dang A; Fernandes H; Ramachandra S; Lin T; Peng B
    Int J Clin Lab Res; 1992; 22(4):220-34. PubMed ID: 1467538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.